Accelerating Clinical Trial Implementation in the Context of the COVID-19 Pandemic: Challenges, Lessons Learned and Recommendations from DisCoVeRy and the EU-SolidAct EU Response Group - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Clinical Microbiology and Infection Année : 2022

Accelerating Clinical Trial Implementation in the Context of the COVID-19 Pandemic: Challenges, Lessons Learned and Recommendations from DisCoVeRy and the EU-SolidAct EU Response Group

Dates et versions

hal-03793453 , version 1 (01-10-2022)

Identifiants

Citer

Alpha Diallo, Marius Troseid, Victoria Charlotte Simensen, Anaïs Boston, Jacques Demotes, et al.. Accelerating Clinical Trial Implementation in the Context of the COVID-19 Pandemic: Challenges, Lessons Learned and Recommendations from DisCoVeRy and the EU-SolidAct EU Response Group. Clinical Microbiology and Infection, 2022, 28 (1), pp.1--5. ⟨10.1016/j.cmi.2021.10.011⟩. ⟨hal-03793453⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More